• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生长抑素:肾上腺功能不全时促肾上腺皮质激素分泌过多的强效抑制剂。

Somatostatin: a potent inhibitor of ACTH-hypersecretion in adrenal insufficiency.

作者信息

Fehm H L, Voigt K H, Lang R, Beinert K E, Raptis S, Pfeiffer E F

出版信息

Klin Wochenschr. 1976 Feb 15;54(4):173-5. doi: 10.1007/BF01468882.

DOI:10.1007/BF01468882
PMID:1256005
Abstract

Somatostatin (250 mug as a bolus i.v. and 250 mug as a 1-hr infusion) was administered to 5 patients with adrenal insufficiency of different origin. In each patient a sustained, progressive fall in plasma ACTH was observed during the infusion period. The mean maximal reduction in plasma ACTH was 43.8 +/- 5.9%. After cessation of the somatostatin infusion there was a rise of plasma ACTH to starting levels within 1/2 hour. These findings suggest that somatostatin is a potent inhibitor of ACTH secretion, however, only in a condition in which glucocorticoids are lacking.

摘要

对5例不同病因所致肾上腺皮质功能不全的患者静脉注射生长抑素(单次推注250微克,随后1小时持续输注250微克)。在输注期间,每例患者血浆促肾上腺皮质激素(ACTH)均持续、进行性下降。血浆ACTH平均最大降幅为43.8±5.9%。生长抑素输注停止后,血浆ACTH在半小时内升至起始水平。这些结果提示,生长抑素是ACTH分泌的强效抑制剂,不过,仅在缺乏糖皮质激素的情况下如此。

相似文献

1
Somatostatin: a potent inhibitor of ACTH-hypersecretion in adrenal insufficiency.生长抑素:肾上腺功能不全时促肾上腺皮质激素分泌过多的强效抑制剂。
Klin Wochenschr. 1976 Feb 15;54(4):173-5. doi: 10.1007/BF01468882.
2
No inhibition of corticotrophin (ACTH)-hypersecretion in adrenal insufficiency by somatostatin.生长抑素对肾上腺皮质功能不全时促肾上腺皮质激素(ACTH)分泌过多无抑制作用。
Acta Endocrinol (Copenh). 1980 Sep;95(1):71-4. doi: 10.1530/acta.0.0950071.
3
Effects of somatostatin and bromocryptine on the plasma ACTH level in bilaterally adrenalectomized patients with Cushing's disease.生长抑素和溴隐亭对双侧肾上腺切除的库欣病患者血浆促肾上腺皮质激素水平的影响。
Endokrinologie. 1980 Jul;76(1):68-72.
4
Inhibition by somatostatin of ACTH secretion in Nelson's syndrome.生长抑素对纳尔逊综合征中促肾上腺皮质激素分泌的抑制作用。
J Clin Endocrinol Metab. 1975 Jun;40(6):1125-7. doi: 10.1210/jcem-40-6-1125.
5
[STUDIES ON THE PITUITARY RESERVE IN PRODUCING ACTH].[关于垂体分泌促肾上腺皮质激素储备功能的研究]
Endokrynol Pol. 1963 Sep-Oct;14:389-407.
6
Failure of somatostatin and octreotide to acutely affect the hypothalamic-pituitary-adrenal function in patients with corticotropin hypersecretion.生长抑素和奥曲肽对促肾上腺皮质激素分泌过多患者的下丘脑-垂体-肾上腺功能无急性影响。
J Endocrinol Invest. 1990 Mar;13(3):257-61. doi: 10.1007/BF03349555.
7
[Experience in the use of competitive binding of hormones with proteins for the determination of non-metabolized glucocorticoids in the blood and urine in some pituitary-adrenal diseases].[利用激素与蛋白质竞争性结合法测定某些垂体 - 肾上腺疾病患者血液及尿液中未代谢糖皮质激素的经验]
Probl Endokrinol (Mosk). 1975 May-Jun;21(3):36-41.
8
[TEST OF ADRENAL CORTEX STIMULATION WITH SYNTHETIC ACTH (BETA 1-24-CORTICOTROPIN)].[用合成促肾上腺皮质激素(β1 - 24 - 促肾上腺皮质激素)进行肾上腺皮质刺激试验]
Endocrinol Sci Cost. 1963;27:405-12.
9
Factors predicting the duration of adrenal insufficiency in patients successfully treated for Cushing disease and nonmalignant primary adrenal Cushing syndrome.预测库欣病及非恶性原发性肾上腺库欣综合征成功治疗患者肾上腺功能不全持续时间的因素。
Endocrine. 2017 Mar;55(3):969-980. doi: 10.1007/s12020-016-1007-5. Epub 2016 Jul 9.
10
Positive rate-sensitive corticosteroid feedback mechanism of ACTH secretion in Cushing's disease.库欣病中促肾上腺皮质激素(ACTH)分泌的阳性率敏感性皮质类固醇反馈机制。
J Clin Invest. 1979 Jul;64(1):102-8. doi: 10.1172/JCI109428.

引用本文的文献

1
Glucocorticoid Receptor Antagonism Upregulates Somatostatin Receptor Subtype 2 Expression in ACTH-Producing Neuroendocrine Tumors: New Insight Based on the Selective Glucocorticoid Receptor Modulator Relacorilant.糖皮质激素受体拮抗剂上调 ACTH 分泌型神经内分泌肿瘤中生长抑素受体亚型 2 的表达:基于选择性糖皮质激素受体调节剂瑞卡鲁肽的新见解。
Front Endocrinol (Lausanne). 2022 Jan 4;12:793262. doi: 10.3389/fendo.2021.793262. eCollection 2021.
2
The Treatment of Cushing's Disease.库欣病的治疗
Endocr Rev. 2015 Aug;36(4):385-486. doi: 10.1210/er.2013-1048. Epub 2015 Jun 11.
3
Mid-gut ACTH-secreting neuroendocrine tumor unmasked with (18)F-dihydroxyphenylalanine-positron emission tomography.

本文引用的文献

1
Effects of somatostatin on plasma glucose and glucagon levels in human diabetes mellitus. Pathophysiologic and therapeutic implications.生长抑素对人类糖尿病患者血糖及胰高血糖素水平的影响。病理生理学及治疗意义。
N Engl J Med. 1974 Sep 12;291(11):544-7. doi: 10.1056/NEJM197409122911102.
2
Effect of somatostatin in patients with acromegaly: suppression of growth hormone, prolactin, insulin and glucose levels.生长抑素对肢端肥大症患者的影响:生长激素、催乳素、胰岛素和血糖水平的抑制作用。
N Engl J Med. 1974 Apr 25;290(17):935-8. doi: 10.1056/NEJM197404252901704.
3
Primary structure of somatostatin, a hypothalamic peptide that inhibits the secretion of pituitary growth hormone.
经(18)F-二羟基苯丙氨酸正电子发射断层扫描发现的中肠促肾上腺皮质激素分泌性神经内分泌肿瘤
Endocrinol Diabetes Metab Case Rep. 2015;2015:140104. doi: 10.1530/EDM-14-0104. Epub 2015 Mar 1.
4
Molecular basis of pharmacological therapy in Cushing's disease.库欣病药物治疗的分子基础。
Endocrine. 2014 Jun;46(2):181-98. doi: 10.1007/s12020-013-0098-5. Epub 2013 Nov 23.
5
New avenues in the medical treatment of Cushing's disease: corticotroph tumor targeted therapy.库欣病治疗的新途径:促肾上腺皮质激素细胞瘤靶向治疗。
J Neurooncol. 2013 Aug;114(1):1-11. doi: 10.1007/s11060-013-1151-1. Epub 2013 May 15.
6
Constitutive somatostatin receptor activity determines tonic pituitary cell response.组成型生长抑素受体活性决定垂体细胞的紧张性反应。
Mol Endocrinol. 2009 Mar;23(3):337-48. doi: 10.1210/me.2008-0361. Epub 2009 Jan 8.
7
Somatostatin and dopamine receptors as targets for medical treatment of Cushing's Syndrome.生长抑素和多巴胺受体作为库欣综合征医学治疗的靶点。
Rev Endocr Metab Disord. 2009 Jun;10(2):91-102. doi: 10.1007/s11154-008-9082-4. Epub 2008 Jul 19.
8
The role of somatostatin analogs in Cushing's disease.生长抑素类似物在库欣病中的作用。
Pituitary. 2004;7(4):257-64. doi: 10.1007/s11102-005-1404-x.
9
Use of octreotide acetate for control of symptoms in patients with islet cell tumors.醋酸奥曲肽用于控制胰岛细胞瘤患者的症状。
World J Surg. 1993 Jul-Aug;17(4):504-10. doi: 10.1007/BF01655110.
10
Long-term treatment of Nelson's syndrome by octreotide: a case report.奥曲肽长期治疗纳尔逊综合征:一例报告
J Endocrinol Invest. 1994 Feb;17(2):135-9. doi: 10.1007/BF03347703.
生长抑素的一级结构,一种抑制垂体生长激素分泌的下丘脑肽。
Proc Natl Acad Sci U S A. 1973 Mar;70(3):684-8. doi: 10.1073/pnas.70.3.684.
4
Effect of somatostatin on plasma glucose and insulin responses to glucagon and tolbutamide in man.生长抑素对人体血浆葡萄糖及胰岛素对胰高血糖素和甲苯磺丁脲反应的影响。
J Clin Endocrinol Metab. 1974 Dec;39(6):1057-60. doi: 10.1210/jcem-39-6-1057.
5
Long-term infusion of growth hormone release inhibiting hormone in acromegaly: effects on pituitary and pancreatic hormones.长期输注生长抑素治疗肢端肥大症:对垂体和胰腺激素的影响。
Br Med J. 1974 Dec 14;4(5945):622-7. doi: 10.1136/bmj.4.5945.622.
6
Spontaneous and stimulated secretion of QUSO-extractable immunoassayable ACTH in man.人体中可通过QUSO提取并进行免疫测定的促肾上腺皮质激素(ACTH)的自发分泌和刺激分泌。
Klin Wochenschr. 1974 Jun 1;52(11):516-21. doi: 10.1007/BF01468721.
7
Effects of somatostatin on the secretion of thyrotropin and prolactin.生长抑素对促甲状腺激素和催乳素分泌的影响。
Endocrinology. 1974 Oct;95(4):968-77. doi: 10.1210/endo-95-4-968.
8
Effects of growth-hormone release-inhibiting hormone on circulating glucagon, insulin, and growth hormone in normal, diabetic, acromegalic, and hypopituitary patients.生长激素释放抑制激素对正常、糖尿病、肢端肥大症和垂体功能减退患者循环中胰高血糖素、胰岛素和生长激素的影响。
Lancet. 1974 Apr 20;1(7860):697-701. doi: 10.1016/s0140-6736(74)92903-1.
9
Inhibition of insulin secretion by somatostatin.生长抑素对胰岛素分泌的抑制作用。
Lancet. 1973 Dec 8;2(7841):1299-301. doi: 10.1016/s0140-6736(73)92873-0.
10
Action of growth-hormone-release inhibitory hormone in healthy men and in acromegaly.生长激素释放抑制激素在健康男性和肢端肥大症患者中的作用。
Lancet. 1973 Sep 15;2(7829):581-4. doi: 10.1016/s0140-6736(73)92413-6.